Research Calls
-
Upgrades:
- Check Point Software (CHKP) upgraded to Outperform from Mkt Perform at William Blair
- Commvault Systems (CVLT) upgraded to Overweight from Sector Weight at KeyBanc Capital Markets; tgt $109
- Core Scientific (CORZ) upgraded to Buy from Neutral at Compass Point; tgt raised to $8.50
- SM Energy (SM) upgraded to Buy from Neutral at Seaport Research Partners; tgt $50
-
Downgrades:
- 2seventy bio (TSVT) downgraded to Market Perform from Outperform at TD Cowen
- Crexendo (CXDO) downgraded to Neutral from Buy at B. Riley Securities; tgt raised to $6.75
- Deutsche Bank (DB) downgraded to Neutral from Buy at Citigroup
- Eagle Bulk Shipping (EGLE) downgraded to Hold from Buy at Jefferies; tgt $55
- Ericsson (ERIC) downgraded to Sell from Neutral at UBS
- Euronav (EURN) downgraded to Hold from Buy at Jefferies; tgt lowered to $18
- Fortune Brands Innovations (FBIN) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt raised to $82
- Johnson Controls (JCI) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $60
- SoFi Technologies (SOFI) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $6.50
- Southwestern Energy (SWN) downgraded to Neutral from Buy at Seaport Research Partners
- Verizon (VZ) downgraded to Equal Weight from Overweight at Barclays; tgt $44
- Vertex Pharma (VRTX) downgraded to Underperform from Neutral at Robert W. Baird; tgt $325
-
Others:
- BridgeBio Pharma (BBIO) initiated with a Market Perform at BMO Capital Markets; tgt $37
- ESSA Pharma (EPIX) initiated with a Buy at Jones Trading
- Northwest Natural (NWN) initiated with a Neutral at Janney; tgt $39
- Sarepta Therapeutics (SRPT) initiated with an Outperform at BMO Capital Markets; tgt $170
- Silence Therapeutics (SLN) initiated with an Outperform at BMO Capital Markets; tgt $67
- Toast (TOST) initiated with a Sector Perform at RBC Capital Mkts; tgt $19